{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:05:52Z","timestamp":1791947152761,"version":"4.3.4"},"reference-count":175,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Loss and gain of functions mutations in the X-linked\n                    <jats:italic>MECP2<\/jats:italic>\n                    (methyl-CpG-binding protein 2) gene are responsible for a set of generally severe neurological disorders that can affect both genders. In particular,\n                    <jats:italic>Mecp2<\/jats:italic>\n                    deficiency is mainly associated with Rett syndrome (RTT) in girls, while duplication of the\n                    <jats:italic>MECP2<\/jats:italic>\n                    gene leads, mainly in boys, to the\n                    <jats:italic>MECP2<\/jats:italic>\n                    duplication syndrome (MDS). No cure is currently available for\n                    <jats:italic>MECP2<\/jats:italic>\n                    related disorders. However, several studies have reported that by re-expressing the wild-type gene is possible to restore defective phenotypes of\n                    <jats:italic>Mecp2<\/jats:italic>\n                    null animals. This proof of principle endorsed many laboratories to search for novel therapeutic strategies to cure RTT. Besides pharmacological approaches aimed at modulating MeCP2-downstream pathways, genetic targeting of\n                    <jats:italic>MECP2<\/jats:italic>\n                    or its transcript have been largely proposed. Remarkably, two studies focused on augmentative gene therapy were recently approved for clinical trials. Both use molecular strategies to well-control gene dosage. Notably, the recent development of genome editing technologies has opened an alternative way to specifically target\n                    <jats:italic>MECP2<\/jats:italic>\n                    without altering its physiological levels. Other attractive approaches exclusively applicable for nonsense mutations are the translational read-through (TR) and t-RNA suppressor therapy. Reactivation of the\n                    <jats:italic>MECP2<\/jats:italic>\n                    locus on the silent X chromosome represents another valid choice for the disease. In this article, we intend to review the most recent genetic interventions for the treatment of RTT, describing the current state of the art, and the related advantages and concerns. We will also discuss the possible application of other advanced therapies, based on molecular delivery through nanoparticles, already proposed for other neurological disorders but still not tested in RTT.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2023.1172805","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:54:26Z","timestamp":1684976066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Michela","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Pozzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Landsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64833","article-title":"Deleting Mecp2 from the cerebellum rather than its neuronal subtypes causes a delay in motor learning in mice","volume":"10","author":"Achilly","year":"2021","journal-title":"eLife"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1073858402239591","article-title":"The neurobiology of Rett syndrome","volume":"9","author":"Akbarian","year":"2003","journal-title":"Neuroscientist"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1557\/s43577-021-00169-2","article-title":"Nucleic acid delivery and nanoparticle design for COVID vaccines","volume":"46","author":"Andresen","year":"2021","journal-title":"MRS Bull."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00005072-199503000-00006","article-title":"Selective dendritic alterations in the cortex of Rett syndrome","volume":"54","author":"Armstrong","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nn.2275","article-title":"Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology","volume":"12","author":"Ballas","year":"2009","journal-title":"Nat. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0092-8674(88)90253-x","article-title":"An unwinding activity that covalently modifies its double-stranded RNA substrate","volume":"55","author":"Bass","year":"1988","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1212\/wnl.45.8.1581","article-title":"Pervasive neuroanatomic abnormalities of the brain in three cases of Rett\u2019s syndrome","volume":"45","author":"Bauman","year":"1995","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/cercor\/bhv078","article-title":"Defects during mecp2 null embryonic cortex development precede the onset of overt neurological symptoms","volume":"26","author":"Bedogni","year":"2016","journal-title":"Cereb. Cortex"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1074\/jbc.M114.608125","article-title":"Methyl-CpG binding protein 2 (MeCP2) localizes at the centrosome and is required for proper mitotic spindle organization","volume":"290","author":"Bergo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol. Ther."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"12591","DOI":"10.1073\/pnas.1413620111","article-title":"Genetic and pharmacological reactivation of the mammalian inactive X chromosome","volume":"111","author":"Bhatnagar","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/bs.pmbts.2020.12.010","article-title":"Application of CRISPR-Cas systems in neuroscience","volume":"178","author":"Bonnerjee","year":"2021","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J. Mol. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.bbi.2020.06.032","article-title":"Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters","volume":"89","author":"Bryche","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106083","DOI":"10.1016\/j.nbd.2023.106083","article-title":"A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain","volume":"180","author":"Carli","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1210\/jc.2011-3002","article-title":"Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients","volume":"97","author":"Carpentier","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"E668","DOI":"10.1073\/pnas.1715124115","article-title":"A mixed modality approach towards xi reactivation for Rett syndrome and other X-linked disorders","volume":"115","author":"Carrette","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/281602a0","article-title":"Suppression of the nonsense mutation in homozygous beta 0 thalassaemia","volume":"281","author":"Chang","year":"1979","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the end game: DNA double-strand break repair pathway choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.cell.2017.04.035","article-title":"Modeling Rett syndrome using TALEN-edited MECP2 mutant Cynomolgus monkeys","volume":"169","author":"Chen","year":"2017","journal-title":"Cells"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"42790","DOI":"10.1038\/srep42790","article-title":"Regulation of mRNA splicing by MeCP2 via epigenetic modifications in the brain","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.devcel.2014.01.032","article-title":"MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8\/Drosha complex","volume":"28","author":"Cheng","year":"2014","journal-title":"Dev. Cell"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1093\/hmg\/dds208","article-title":"Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows","volume":"21","author":"Cheval","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e1009087","DOI":"10.1371\/journal.pgen.1009087","article-title":"Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing","volume":"16","author":"Chhatbar","year":"2020","journal-title":"PLoS Genet."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/cercor\/bhx360","article-title":"Lack of methyl-CpG binding protein 2 (MeCP2) affects cell fate refinement during embryonic cortical development","volume":"28","author":"Cobolli Gigli","year":"2018","journal-title":"Cereb. Cortex"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1006\/nbdi.2001.0428","article-title":"Gene expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification","volume":"8","author":"Colantuoni","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e12739","DOI":"10.1111\/gbb.12739","article-title":"Safety and efficacy of genetic MECP2 supplementation in the R294X mouse model of Rett syndrome","volume":"21","author":"Collins","year":"2022","journal-title":"Genes Brain Behav."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.2147\/NDT.S371483","article-title":"Rett syndrome and MECP2 duplication syndrome: disorders of mecp2 dosage","volume":"18","author":"Collins","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41431-020-0624-x","article-title":"High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot","volume":"28","author":"Croci","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J. Med. Genet."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/mtm.2013.5","article-title":"Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with Adeno-associated viral vectors","volume":"1","author":"de Leeuw","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12017-015-8363-9","article-title":"Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome","volume":"17","author":"Del\u00e9pine","year":"2015","journal-title":"Neuromolecular Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/acn3.51306","article-title":"Ataluren for drug-resistant epilepsy in nonsense variant-mediated Dravet syndrome and CDKL5 deficiency disorder","volume":"8","author":"Devinsky","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1556-276X-9-252","article-title":"A sight on the current nanoparticle-based gene delivery vectors","volume":"9","author":"Dizaj","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1007\/s11033-019-04983-5","article-title":"Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients","volume":"46","author":"Duma","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1134\/S0006297911130049","article-title":"Y-box-binding protein 1 (YB-1) and its functions","volume":"76","author":"Eliseeva","year":"2011","journal-title":"Biochem. Moscow"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/sj.ejhg.5201451","article-title":"Early onset seizures and Rett-like features associated with mutations in CDKL5","volume":"13","author":"Evans","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/mp.2011.180","article-title":"Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations","volume":"17","author":"Farra","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1080\/15476286.2019.1632633","article-title":"Aminoglycoside drugs induce efficient read-through ofCDKL5nonsense mutations, slightly restoring its kinase activity","volume":"16","author":"Fazzari","year":"2019","journal-title":"RNA Biol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.4161\/cc.8.24.10245","article-title":"Over the barrier and through the blood: to CNS delivery we go","volume":"8","author":"Foust","year":"2009","journal-title":"Cell Cycle"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.addr.2020.02.006","article-title":"Intrathecal drug delivery in the era of nanomedicine","author":"Fowler","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e10270","DOI":"10.15252\/emmm.201910270","article-title":"MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders","volume":"12","author":"Frasca","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6956934","article-title":"Analysis of the phenotypes in the rett networked database","volume":"2019","author":"Frullanti","year":"2019","journal-title":"Int. J. Genomics"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1177\/08830738030180100301","article-title":"InterRett and RettBASE: international Rett syndrome association databases for Rett syndrome","volume":"18","author":"Fyfe","year":"2003","journal-title":"J. Child Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuron.2008.07.030","article-title":"Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress","volume":"59","author":"Fyffe","year":"2008","journal-title":"Neuron"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","article-title":"Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome","volume":"5","author":"Gadalla","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"601626","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1007\/s12035-018-1412-2","article-title":"A novel Mecp2Y120D Knock-in model displays similar behavioral traits but distinct molecular features compared to the Mecp2-null mouse implying precision medicine for the treatment of Rett syndrome","volume":"56","author":"Gandaglia","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J. Neurosci."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of a\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nn.2997","article-title":"Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses","volume":"15","author":"Goffin","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"620859","DOI":"10.3389\/fgene.2021.620859","article-title":"Mecp2: the genetic driver of rett syndrome epigenetics","volume":"12","author":"Good","year":"2021","journal-title":"Front. Genet."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"","journal-title":"Hum. Gene Ther."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"","journal-title":"Mol. Ther."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.neuron.2021.03.011","article-title":"Enhancer viruses for combinatorial cell-subclass-specific labeling","volume":"109","author":"Graybuck","year":"2021","journal-title":"Neuron"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"e2105245118","DOI":"10.1073\/pnas.2105245118","article-title":"Biotransformation modulates the penetration of metallic nanomaterials across an artificial blood-brain barrier model","volume":"118","author":"Guo","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"698812","DOI":"10.3389\/fnins.2021.698812","article-title":"Pre-clinical investigation of Rett syndrome using human stem cell-based disease models","volume":"15","author":"Haase","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Invest."},{"key":"ref74","first-page":"783","article-title":"Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy","volume":"9","author":"Hamed","year":"2006","journal-title":"IDrugs"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"eaba9188","DOI":"10.1126\/scitranslmed.aba9188","article-title":"MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates","volume":"12","author":"Hordeaux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1096\/fj.06-7380com","article-title":"Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"21","author":"Huang","year":"2007","journal-title":"FASEB J."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","article-title":"Rett syndrome: insights into genetic, molecular and circuit mechanisms","volume":"19","author":"Ip","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2202-11-19","article-title":"Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome\/X-linked mental retardation","volume":"11","author":"Jentarra","year":"2010","journal-title":"BMC Neurosci."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm.4406","article-title":"Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome","volume":"23","author":"Johnson","year":"2017","journal-title":"Nat. Med."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat. Genet."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.3390\/ijms20153813","article-title":"Glial dysfunction in mecp2 deficiency models: implications for rett syndrome","volume":"20","author":"Kahanovitch","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3892\/ijmm.2014.1809","article-title":"Therapeutic suppression of premature termination codons: mechanisms and clinical considerations (review)","volume":"34","author":"Karijolich","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","article-title":"MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions","volume":"27","author":"Kishi","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"eabb3945","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1172\/JCI90967","article-title":"Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes","volume":"127","author":"Lamonica","year":"2017","journal-title":"J. Clin. Invest."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fgene.2019.00625","article-title":"Efficient and precise CRISPR\/Cas9-mediated MECP2 modifications in human-induced pluripotent stem cells","volume":"10","author":"le","year":"2019","journal-title":"Front. Genet."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11689-020-09332-3","article-title":"A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance","volume":"12","author":"Lee","year":"2020","journal-title":"J. Neurodev. Disord."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-o","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cells"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbrc.2023.01.057","article-title":"Human MECP2 transgenic rats show increased anxiety, severe social deficits, and abnormal prefrontal neural oscillation stability","volume":"648","author":"Li","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"E1575","DOI":"10.1073\/pnas.1517244113","article-title":"Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature10214","article-title":"A role for glia in the progression of Rett\u2019s syndrome","volume":"475","author":"Lioy","year":"2011","journal-title":"Nature"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI78167","article-title":"MECP2 disorders: from the clinic to mice and back","volume":"125","author":"Lombardi","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e52629","DOI":"10.7554\/eLife.52629","article-title":"Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome","volume":"9","author":"Luoni","year":"2020","journal-title":"eLife"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11689-018-9234-0","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","article-title":"Rett syndrome: a complex disorder with simple roots","volume":"16","author":"Lyst","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nn.3434","article-title":"Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor","volume":"16","author":"Lyst","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"12221","DOI":"10.1074\/jbc.271.21.12221","article-title":"Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase","volume":"271","author":"Maas","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J. Neurosci."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"105235","DOI":"10.1016\/j.nbd.2020.105235","article-title":"Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome","volume":"149","author":"Matagne","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.009","article-title":"A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome","volume":"99","author":"Matagne","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neulet.2017.11.049","article-title":"Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain","volume":"665","author":"Matsuzaki","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMra032207","article-title":"Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency","volume":"350","author":"McCormack","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.1206593","article-title":"Adult neural function requires MeCP2","volume":"333","author":"McGraw","year":"2011","journal-title":"Science"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/379460a0","article-title":"A mammalian RNA editing enzyme","volume":"379","author":"Melcher","year":"1996","journal-title":"Nature"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/hmg\/ddaa102","article-title":"Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome","volume":"29","author":"Merritt","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/357455a0","article-title":"Human gene therapy comes of age","volume":"357","author":"Miller","year":"1992","journal-title":"Nature"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng1327","article-title":"A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome","volume":"36","author":"Mnatzakanian","year":"2004","journal-title":"Nat. Genet."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/cbic.202000364","article-title":"In vivoTargeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long\u2010Lasting Immunity against Melanoma","volume":"22","author":"Moku","year":"2021","journal-title":"Chembiochem"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1016\/j.ymthe.2017.08.004","article-title":"AAV-PHP.B-mediated global-scale expression in the mouse nervous system enables GBA1 gene therapy for wide protection from Synucleinopathy","volume":"25","author":"Morabito","year":"2017","journal-title":"Mol. Ther."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease","volume":"29","author":"Mort","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations inMethyl\u2010CpG binding protein 2","volume":"180","author":"Neul","year":"2018","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1073858403260995","article-title":"Rett syndrome: a prototypical neurodevelopmental disorder","volume":"10","author":"Neul","year":"2004","journal-title":"Neuroscientist"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.1523\/JNEUROSCI.1316-12.2012","article-title":"MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain","volume":"32","author":"Nguyen","year":"2012","journal-title":"J. Neurosci."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"18764","DOI":"10.1523\/JNEUROSCI.2657-13.2013","article-title":"Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology","volume":"33","author":"Nguyen","year":"2013","journal-title":"J. Neurosci."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuron.2017.10.004","article-title":"Virus-mediated genome editing via homology-directed repair in mitotic and Postmitotic cells in mammalian brain","volume":"96","author":"Nishiyama","year":"2017","journal-title":"Neuron"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1006\/meth.1998.0605","article-title":"Purification of native and recombinant double-stranded RNA-specific adenosine deaminases","volume":"15","author":"O\u2019Connell","year":"1998","journal-title":"Methods"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/277148a0","article-title":"Phenotypic suppression of nonsense mutants in yeast by aminoglycoside antibiotics","volume":"277","author":"Palmer","year":"1979","journal-title":"Nature"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jmg.2009.067355","article-title":"Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females","volume":"47","author":"Philippe","year":"2010","journal-title":"J. Med. Genet."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/hmg\/ddv030","article-title":"Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene","volume":"24","author":"Pitcher","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.1073\/pnas.1803792115","article-title":"Pharmacological reactivation of inactive X-linkedMecp2in cerebral cortical neurons of living mice","volume":"115","author":"Przanowski","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"eadd4666","DOI":"10.1126\/scitranslmed.add4666","article-title":"Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons","volume":"15","author":"Qian","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"GE01-6","DOI":"10.7860\/JCDR\/2015\/10443.5394","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.21715","article-title":"Autism and other neuropsychiatric symptoms are prevalent in individuals withMeCP2duplication syndrome","volume":"66","author":"Ramocki","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","article-title":"The MECP2 duplication syndrome","author":"Ramocki","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"e6810","DOI":"10.1371\/journal.pone.0006810","article-title":"MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy","volume":"4","author":"Rastegar","year":"2009","journal-title":"PLoS One"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41592-020-0799-7","article-title":"Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types","volume":"17","author":"Ravindra Kumar","year":"2020","journal-title":"Nat. Methods"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s003350010035","article-title":"Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions","volume":"11","author":"Reichwald","year":"2000","journal-title":"Mamm. Genome"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/FBP.0b013e32830c3645","article-title":"Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches","volume":"19","author":"Ricceri","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/hmg\/ddq563","article-title":"Reduced AKT\/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model","volume":"20","author":"Ricciardi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.10633","article-title":"Olfactory biopsies demonstrate a defect in neuronal development in Rett\u2019s syndrome","volume":"54","author":"Ronnett","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human immune responses to Adeno-associated virus (AAV) vectors","volume":"11","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","article-title":"Gene therapy for the CNS using AAVs: the impact of systemic delivery by AAV9","volume":"241","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.conb.2011.06.006","article-title":"Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and met","volume":"21","author":"Shepherd","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/d1nr02065j","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"e2206053119","DOI":"10.1073\/pnas.2206053119","article-title":"Targeted RNA editing in brainstem alleviates respiratory dysfunction in a mouse model of Rett syndrome","volume":"119","author":"Sinnamon","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"E9395","DOI":"10.1073\/pnas.1715320114","article-title":"Site-directed RNA repair of endogenous Mecp2 RNA in neurons","volume":"114","author":"Sinnamon","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"107878","DOI":"10.1016\/j.celrep.2020.107878","article-title":"In vivo repair of a protein underlying a neurological disorder by programmable RNA editing","volume":"32","author":"Sinnamon","year":"2020","journal-title":"Cell Rep."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/brain\/awab182","article-title":"Engineered microRNA-based regulatory element permits safe high-dose miniMECP2gene therapy in Rett mice","volume":"144","author":"Sinnett","year":"2021","journal-title":"Brain: A Journal of Neurology"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","article-title":"Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery","volume":"5","author":"Sinnett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","year":"2010","journal-title":"Mol. Cell"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/hmg\/ddy338","article-title":"Loss of MeCP2 in immature neurons leads to impaired network integration","volume":"28","author":"Sun","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1016\/s0387-7604(01)00362-x","article-title":"The role of X-chromosome inactivation in the manifestation of Rett syndrome","author":"Takagi","year":"2001","journal-title":"Brain Dev."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1399-0004.2007.00944.x","article-title":"Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndrome","volume":"73","author":"Takahashi","year":"2008","journal-title":"Clin. Genet."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.pediatrneurol.2015.06.003","article-title":"The changing face of survival in Rett syndrome and MECP2-related disorders","volume":"53","author":"Tarquinio","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/296537a0","article-title":"Construction of a functional human suppressor tRNA gene: an approach to gene therapy for \u03b2-thalassaemia","volume":"296","author":"Temple","year":"1982","journal-title":"Nature"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.10.004","article-title":"The molecular basis of mecp2 function in the brain","author":"Tillotson","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nature24058","article-title":"Radically truncated MeCP2 rescues Rett syndrome-like neurological defects","volume":"550","author":"Tillotson","year":"2017","journal-title":"Nature"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1086\/444549","article-title":"Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males","volume":"77","author":"van Esch","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"e1901081","DOI":"10.1002\/adma.201901081","article-title":"Cancer-targeting nanoparticles for combinatorial nucleic acid delivery","volume":"32","author":"Vaughan","year":"2020","journal-title":"Adv. Mater."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"e20733","DOI":"10.1371\/journal.pone.0020733","article-title":"Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations","volume":"6","author":"Vecsler","year":"2011","journal-title":"PLoS One"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1093\/hmg\/ddw178","article-title":"Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome","volume":"25","author":"Veeraragavan","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"e12752","DOI":"10.1111\/gbb.12752","article-title":"Profiling beneficial and potential adverse effects ofMeCP2overexpression in a hypomorphic Rett syndrome mouse model","volume":"21","author":"Vermudez","year":"2022","journal-title":"Genes Brain Behav."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yebeh.2016.10.006","article-title":"Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome","volume":"66","author":"Vignoli","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41593-020-0692-9","article-title":"Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans","volume":"23","author":"Vormstein-Schneider","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04533-3","article-title":"AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice","volume":"604","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1021\/bi00600a001","article-title":"Aminoglycoside antibiotics and eukaryotic protein synthesis: structure--function relationships in the stimulation of misreading with a wheat embryo system","volume":"17","author":"Wilhelm","year":"1978","journal-title":"Biochemistry"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41589-018-0080-x","article-title":"Genome editing by natural and engineered CRISPR-associated nucleases","volume":"14","author":"Wu","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12264-022-00974-y","article-title":"Extension of the lifespan of a mouse model of rett syndrome by intracerebroventricular delivery of MECP2","volume":"39","author":"Yang","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/hmg\/ddt640","article-title":"Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome","volume":"23","author":"Yasui","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2040-2392-4-3","article-title":"MeCP2 modulates gene expression pathways in astrocytes","volume":"4","author":"Yasui","year":"2013","journal-title":"Mol. Autism."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target effects in CRISPR\/Cas9-mediated genome engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Molecular therapy. Nucleic acids"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1172805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:54:30Z","timestamp":1684976070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1172805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":175,"alternative-id":["10.3389\/fnins.2023.1172805"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1172805","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"article-number":"1172805"}}